The selling shareholder can begin selling ADSs immediately. Monitor daily volume and price action for signs of distribution. The rapid 6-day turnaround from F-1 filing to effectiveness suggests the SEC processed this quickly — typical for a resale registration — but the overhang is now live.
Price Chart
Executive Summary
The SEC declared effective Biodexa Pharmaceuticals' F-1 registration statement (File No. 333-299106) on September 30, 2026, covering the resale of up to 220,421,800 ordinary shares (represented by 4,408,436 ADSs) underlying Series P warrants from a September 2026 private placement. The company will not receive any proceeds from the resale, only from any warrant exercises. The effectiveness removes the final regulatory barrier for the selling shareholder to begin selling, creating immediate overhang risk for BDRX shares.
Key Facts
- Effectiveness date: September 30, 2026
- Registration covers resale of 220,421,800 ordinary shares (4,408,436 ADSs) underlying Series P warrants
- Company receives no proceeds from the resale; only from any warrant exercises
- Selling shareholder can sell at any time in market transactions
- Last reported ADS closing price on September 23, 2026 was $0.6894
- F-1 was filed September 24, 2026; effectiveness occurred 6 days later
Financial Impact
Up to 220.4M ordinary shares (4.4M ADSs) eligible for immediate resale; at $0.6894/ADS, potential market value of ~$3.04M. This represents substantial dilution relative to current float.
Risk Factors
- Immediate share price pressure from selling shareholder resales beginning immediately
- Potential for accelerated selling given the 6-day gap between F-1 filing to effectiveness
- No company control over timing or pace of selling
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-003123 |
| Document: 9999999995-26-003123-index.html | 9999999995-26-003123 |
| Document: 9999999995-26-003123.txt | 9999999995-26-003123 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 12d ago | 6-K | $0.4849 | awaiting T+20 | — | $3.69 (+660.98%) |
Oct 8, 2026 18d ago | 6-K | $0.4602 | awaiting T+20 | — | $3.69 (+701.83%) |
Oct 1, 2026 26d ago | EFFECT | $0.6326 | awaiting T+20 | — | $3.69 (−483.31%) |
Sep 24, 2026 4w ago | F-1 | $0.6750 $0.4140 | ▲ +38.67% | ▲ +38.25% | $3.69 (−446.67%) |
Sep 15, 2026 5w ago | 6-K | $1.33 $0.3502 | ▼ −73.67% | ▼ −76.65% | $3.69 (+177.44%) |
Sep 11, 2026 6w ago | 6-K | $1.12 $0.3832 | ▲ +65.79% | ▲ +68.05% | $3.69 (−229.46%) |
Aug 4, 2026 12w ago | EFFECT | $11.92 $6.25 | ▲ +47.58% | ▲ +46.35% | $3.69 (+69.04%) |
Jun 30, 2026 16w ago | 6-K | $3.00 $1.45 | ▼ −51.83% | ▼ −49.65% | $3.69 (+23.00%) |
Jun 30, 2026 16w ago | 6-K | $2.91 $1.45 | ▲ +50.34% | ▲ +48.03% | $3.69 (−26.80%) |
Jun 17, 2026 18w ago | 6-K | $3.06 $2.13 | ▼ −30.39% | ▼ −30.93% | $3.69 (+20.59%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers